|
|
|
|
|
|
The latest immunology news from News Medical |
|
|
|
 | |
[Free eBook] Proteomics
Accurate and scalable protein detection by NGS.
In this eBook, you will learn about the Illumina Protein Prep end-to-end workflow and best-in-class performance using SOMAmer® technology for high analytical sensitivity, specificity, and reproducibility. Amplify your discovery power by interrogating 9.5K human proteins and answer your most complex biological questions.
| |
|
|
|
|
 | | Of the 3.6 million babies born in the United States each year, around 80 percent begin breastfeeding in their first month of life. | | | | A Medical University of South Carolina team reports in Frontiers in Immunology that it has engineered a new type of genetically modified immune cell that can precisely target and neutralize antibody-producing cells complicit in organ rejection. | | | | The research group led by Drs. Mitsuru Arase, Mari Murakami, and Prof. Kiyoshi Takeda (Graduate School of Medicine/ Immunology Frontier Research Center at The University of Osaka) revealed that transcription factors RUNX2 and BHLHE40 play crucial roles in inducing T cells involved in Crohn's disease. | | | | Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and collaborators report in the September 10 online issue of Nature that tumors rewire immune cells in the bone marrow before they even reach the cancer, suggesting a new target to enhance the durability of current immunotherapy | | | | Immune-inflammatory skin diseases (e.g., psoriasis, atopic dermatitis) involve dysregulation of CD4+ T-cell subsets (Th1/Th2/Th17/Treg) and cytokine networks (IL-17/IL-23/IL-4). | |
|
|
|
 | | How would you rate today's newsletter?
| |
|
|
|
|